Clinical Trials · NCT02388529
A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure
- Phase
- Phase 1
- Recruitment status
- Withdrawn
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 0
- Start date
- May 2015
- Locations
- 1 site, Bulgaria
- Primary endpoint
- Incidence of Adverse Events